Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 074129

Expand all

NAPROXEN (NAPROXEN)
250MG
Marketing Status: Discontinued

Active Ingredient: NAPROXEN
Proprietary Name: NAPROXEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A074129
Product Number: 001
Approval Date: Dec 21, 1993
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

NAPROXEN (NAPROXEN)
375MG
Marketing Status: Discontinued

Active Ingredient: NAPROXEN
Proprietary Name: NAPROXEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 375MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A074129
Product Number: 002
Approval Date: Dec 21, 1993
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

NAPROXEN (NAPROXEN)
500MG
Marketing Status: Discontinued

Active Ingredient: NAPROXEN
Proprietary Name: NAPROXEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A074129
Product Number: 003
Approval Date: Dec 21, 1993
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information